Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 81. Gruenberg B, Johnson P N, Miller J L, Kumar I, Deen M H, Knoles C. Anti-epileptic medication availability in rural Oklahoma. Journal of Oklahoma State Medical Association. 2018; 111 : 548-553
82. Miller J L, Capino A C, Thomas A, Couloures K, Johnson P N. Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2018; 23 : 72-83
83. Ibach B W, Miller J L, Woo S, Harrison D, Standifer K, Hagemann T M, Johnson P N. Characterization of tolerance in children during fentanyl continuous infusions. J Pediatr Intensive Care. 2017; 6 : 83-90
84. Miller J L, Lepa T M, Ranallo C, Chaaban H, Skrepnek G H, Johnson P N. Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended?. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies. 2017; 18 : e615-e620
85. Johnson P N, Nguyen A, Neely S, Johnson M. Intramuscular Lorazepam for Status Epilepticus in Children With Complex Medical and Physical Disabilities. The Annals of pharmacotherapy. 2017; 51 : 656-662
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 21. Pediatric Pharmacy Advocacy Group. Best Student Investigator Award (Served as student mentor). Date: 2015.
22. University of Oklahoma College of Medicine, Department of Pediatrics. Best Trainee Research Award (Served as resident mentor). Date: 2015.
23. Pediatric Pharmacy Advocacy Group. Special Recognition Award. Date: 2015.
24. ACCP Pediatric Practice and Research Network. Travel Award (Served as student mentor). Date: 2014.
25. Pediatric Pharmacy Advocacy Group. Original Research Award. Date: 2014.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results